| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.22B | -2.9% |
| Cost of Revenue | $2.90B | +8.0% |
| Gross Profit | $3.31B | -10.8% |
| R&D Expense | $366.0M | -22.0% |
| SG&A Expense | $1.72B | -2.2% |
| Interest Expense | $504.0M | -3.1% |
| Pre-tax Income | $425.0M | -47.3% |
| Income Tax | $238.0M | +517.5% |
| Net Income | $187.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $574.0M | -15.0% |
| Accounts Receivable | $1.33B | -2.0% |
| Inventory | $1.41B | +6.4% |
| Current Assets | $4.35B | +0.1% |
| Total Assets | $12.87B | -1.8% |
| Current Liabilities | $2.39B | -12.1% |
| Long-term Debt | $8.64B | -2.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $700.0M | -25.5% |
| Capital Expenditures | $162.0M | -7.4% |
| Investing Cash Flow | -$390.0M | +24.0% |
| Financing Cash Flow | -$561.0M | -52.4% |
| Free Cash Flow | $538.0M | -29.6% |
| -78.4% |
| EPS (Basic) | $0.72 | -78.6% |
| EPS (Diluted) | $0.72 | -78.4% |
| Total Liabilities |
| $12.12B |
| -4.1% |
| Stockholders' Equity | $752.0M | +59.3% |